RxDoctor Payments DataLook up a doctor →

Marc David Spencer, MD

Family Medicine · Englewood, CONPI 1811980733

Payments from drug & device makers

$33,367in general payments, 2019–2025

Across 813 payments — averaging $41.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$20K
  • AbbVie$3K
  • AstraZeneca$977
  • Johnson & Johnson$929
  • Amgen$815
  • GSK$777
  • plus $7K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gilead44$19,941
AbbVie(2 entities)166$2,616
AstraZeneca(2 entities)53$977
Johnson & Johnson55$929
Amgen(2 entities)48$815
GSK49$777
Novo Nordisk37$588
Lilly USA, LLC37$543
Supernus Pharmaceuticals, Inc.4$525
Pfizer40$523
Boehringer Ingelheim32$519
Viiv Healthcare Company21$376
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC24$368
Esperion Therapeutics, Inc.14$275
Merck15$225
Otsuka America Pharmaceutical, Inc.10$210
Medtronic5$186
Novartis11$183
Astellas Pharma US Inc8$164
Bayer9$155
Kowa Pharmaceuticals America, Inc.9$146
Biohaven Pharmaceuticals, Inc.11$142
Eisai Inc.8$126
Inspire Medical Systems, Inc.1$124
Ironshore Pharmaceuticals Inc.3$118
Corium, LLC7$110
Adlon Therapeutics L.p.7$100
Pharmacyclics LLC, An Abbvie Company1$100
Idorsia Pharmaceuticals US Inc5$95
Amneal Pharmaceuticals LLC6$80
Takeda Pharmaceuticals U.S.A., Inc.4$74
Abiomed2$71
Valeritas, Inc.4$70
Sanofi-aventis U.S. LLC4$69
Electromed, Inc.3$64
E.r. Squibb & Sons, L.L.C.3$63
Boston Scientific3$59
Seqirus USA Inc3$57
Exact Sciences3$55
Biohaven Pharmaceutical Holding Company Ltd.2$53
Hologic Sales And Service, LLC4$50
Optinose US, Inc.2$50
Nestle Healthcare Nutrition Inc.3$49
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$46
Lundbeck LLC2$43
Vertical Pharmaceuticals, LLC2$41
Jazz Pharmaceuticals Inc.2$37
Amarin Pharma, Inc.2$30
Ossur Americas, Inc.1$21
Sumitomo Pharma America, Inc.1$21
Paratek Pharmaceuticals, Inc.1$20
Organogenesis Inc.1$18
Mannkind Corporation1$18
Kaleo, Inc.1$17
VBI Vaccine (delaware) Inc.1$16
Tetraphase Pharmaceuticals, Inc.1$16
Assertio Therapeutics, Inc.1$16
Neos Therapeutics, LP1$16
Genentech USA, Inc.1$16
Aimmune Therapeutics, Inc.1$16

How this compares

$33,367 in reported general payments places this provider in the 95th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado →

Medicare billing

Part B allowed, 2024
$104,866
Medicare patients
272
Services billed
2,152

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Englewood

See the full list for Colorado →

Where these figures come from

Is this you, or does something look wrong? →